![Lars Göran Leonardsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Lars Göran Leonardsson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Oncorena AB
![]() Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lars Göran Leonardsson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Oncorena Holding AB
![]() Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Ferring Pharmaceuticals A/S
![]() Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Egalet Ltd.
![]() Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Clinitrac AB
![]() Clinitrac AB Packaged SoftwareTechnology Services Clinitrac AB develops wireless patient diaries. The firm offers solutions for pharmaceutical, biotechnology, and medical device companies. The company was founded in 1995 and is located in Stockholm, Sweden. | Packaged Software | President | |
Forska Sverige
![]() Forska Sverige Miscellaneous Commercial ServicesCommercial Services Forska Sverige provides medical research services. | Miscellaneous Commercial Services | Director/Board Member | |
CARISMA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
HealthCap AB
![]() HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Founder | |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Healthcap Annex Fund I-Ii Bis Gp AB
![]() Healthcap Annex Fund I-Ii Bis Gp AB Financial ConglomeratesFinance Healthcap Annex Fund I-Ii Bis Gp AB operates as an investment holding Swedish company. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Chairman | |
Healthcap 1999 Orx Holdings AB
![]() Healthcap 1999 Orx Holdings AB Investment Banks/BrokersFinance Healthcap 1999 Orx Holdings AB acquires and manages securities and other movable properties. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Chairman | |
Healthcap Sidefund Orx Holding AB
![]() Healthcap Sidefund Orx Holding AB Investment Banks/BrokersFinance Healthcap Sidefund Orx Holding AB provides securities brokerage and real estate property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Chairman | |
Eksse AB
![]() Eksse AB Financial ConglomeratesFinance Eksse AB is a Swedish company that acquires and manages securities and related investment properties. The private company is based in Sundsvall, Sweden. | Financial Conglomerates | Chairman | |
Shoemaxer AB
![]() Shoemaxer AB Apparel/Footwear RetailRetail Trade Shoemaxer AB is a Swedish company that wholesales clothing and footwear. The private company is based in Stockholm, Sweden. | Apparel/Footwear Retail | Director/Board Member | |
Paulina Berglund Arkitekter AB
![]() Paulina Berglund Arkitekter AB Engineering & ConstructionIndustrial Services Paulina Berglund Arkitekter AB provides architectural services. The private company is based in Stockholm, Sweden. | Engineering & Construction | Director/Board Member | |
University of Uppsala | College/University | Masters Business Admin | |
Sunstone Capital A/S
![]() Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Investment Managers | Private Equity Investor | |
Healthcap Partners AB
![]() Healthcap Partners AB Investment ManagersFinance Healthcap Partners AB is a venture capital fund. The private company is based in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal | |
The University of Colorado School of Medicine | College/University | Graduate Degree | |
Belina Pharma AB
![]() Belina Pharma AB Miscellaneous Commercial ServicesCommercial Services Belina Pharma AB researches, develops, markets, and trades drugs against breast cancer. The company is headquartered in Helsingborg, Sweden. | Miscellaneous Commercial Services | Chairman | |
Belina AB | Chairman | ||
Lund University Hospital | Corporate Officer/Principal | ||
ODINWELL AB | Packaged Software | Director/Board Member | |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Southern Denmark | College/University | Graduate Degree | |
University of Lund | College/University | Doctorate Degree | |
Royal Institute of Technology | College/University | Graduate Degree | |
GENOVIS AB | Medical Specialties | Director/Board Member | |
Sylentis SA
![]() Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Biotechnology | Chief Executive Officer | |
DEXTECH MEDICAL AB | Pharmaceuticals: Major | Chairman | |
Eir Ventures Danmark ApS | Investment Managers | Private Equity Investor | |
Prexton Therapeutics SA
![]() Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
Barbastellen AB
![]() Barbastellen AB Media ConglomeratesConsumer Services Barbastellen AB provides literary and artistic creation services. The private company is based in Stockholm, Sweden. | Media Conglomerates | Corporate Officer/Principal | |
KK Stiftelsen | Investment Trusts/Mutual Funds | Director/Board Member | |
Healthcap Vii Advisor AB
![]() Healthcap Vii Advisor AB Investment ManagersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap Vii Advisor AB is a company that provides fund, PPM and pension management services. The company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Q-Med AB
![]() Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
Shire Orphan Therapies GmbH
![]() Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Nordic Vision Clinics AS
![]() Nordic Vision Clinics AS Hospital/Nursing ManagementHealth Services Part of NVC Holding AB, Nordic Vision Clinics AS is a Norwegian company that provides laser eye surgery. The company is based in Oslo, Norway. | Hospital/Nursing Management | Director/Board Member | |
LTB4 Sweden AB
![]() LTB4 Sweden AB BiotechnologyHealth Technology LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member | |
HealthCap Advisor AB
![]() HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
OFP V Advisor AB | Chief Executive Officer | ||
Hydrargyr AB | Director/Board Member | ||
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
Sweden | 34 |
Denmark | 6 |
United States | 6 |
Norway | 3 |
France | 2 |
Sectoral
Health Technology | 21 |
Finance | 11 |
Consumer Services | 7 |
Commercial Services | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 50 |
Chairman | 15 |
Corporate Officer/Principal | 9 |
Independent Dir/Board Member | 6 |
Chief Executive Officer | 6 |
Most connected contacts
- Stock Market
- Insiders
- Lars Göran Leonardsson
- Company connections